Bacteriology

Section 1: Principles of Identification

Chapter 13 Overview of Bacterial

Identification Methods and Strategies, 216

Rationale for a Method of Organism Identification, 216 How to Use Part HI: Bacteriology, 216

Chapter 14 General Considerations and Applications of Information Provided in Bacterial Sections of Part m, 248

Rationale for Approaching Organism Identification, 248

Chapter 15 Bacterial Identification Flow Charts and Schemes: A Guide to Part m, 251

Chapter 18

Chapter 19

Catalase-Positive, GramPositive Cocci

Staphylococcus, Micrococcus, and Similar Organisms, 254

General Characteristics, 254 Epidemiology, 254 Pathogenesis and Spectrum of Disease, 254

Laboratory Diagnosis, 256 Antimicrobial Susceptibility Testing and Therapy, 261

Catalase-Negative, GramPositive Cocci

Streptococcus, Enterococcus, and Similar Organisms, 265

General Characteristics, 265 Epidemiology, 265 Pathogenesis and Spectrum of Disease, 266

Laboratory Diagnosis, 269 Antimicrobial Susceptibility Testing and Therapy, 277 Prevention, 278

Non-Branching, Catalase-Positive, Gram-Positive Bacilli

Bacillus and Similar Organisms, 281

General Characteristics, 281 Epidemiology, 281 Pathogenesis and Spectrum of Disease, 281

Laboratory Diagnosis, 281 Antimicrobial Susceptibility Testing and Therapy, 286 Prevention, 286

Listeria, Corynebacterium, and Similar Organisms, 228

General Characteristics, 288 Epidemiology, 288 Pathogenesis and Spectrum of Disease, 288

Laboratory Diagnosis, 288 Antimicrobial Susceptibility Testing and Therapy, 297 Prevention, 300

Section 5: Non-Branching, Catalase-Negative, Gram-Positive Bacilli

Erysipelothrix, Lactobacillus, and Similar Organisms, 303

General Characteristics, 303 Epidemiology, Pathogenesis, and Spectrum of Disease, 303 Labortory Diagnosis, 303 Antimicrobial Susceptibility Testing and Therapy, 308 Prevention, 308

Branching or Partially Acid-Fast, Gram-Positive Bacilli

Nocardia, Streptomyces, Rhodococcus, and Similar Organisms, 311

General Characteristics, 31] Epidemiology and Pathogenesis, 313 Spectrum of Disease, 313 Laboratory Diagnosis, 315 Antimicrobial Susceptibility Testing and Therapy, 320 Prevention, 320

Gram-Negative Bacilli and Coccobacilli (MacConkey-Positive, Oxidase-Negative)

Enterobaeteriaceae, 323

Genera and Species to Be Considered, 323 General Characteristics, 323 Epidemiology, 323 Pathogenesis and Spectrum of Disease, 323

Laboratory Diagnosis, 324 Antimicrobial Susceptibility Testing and Therapy, 330 Prevention, 330

ter 23 Acinetobacter, Stenotrophomonas, and Other Organisms, 334

General Characteristics, 334 Epidemiology, 334 Pathogenesis and Spectrum of Disease, 334

Laboratory Diagnosis, 334 Antimicrobial Susceptibility Testing and Therapy, 337 Prevention, 338

Section 8: Gram-Negative Bacilli and Coccobacilli (MacConkey-Positive, Oxidase-Positive)

Chapter 24 Pseudomonas, Burkholderia, and Similar Organisms, 340

General Characteristics, 340 Epidemiology, 340 Pathogenesis and Spectrum of Disease, 342

Laboratory Diagnosis, 343 Antimicrobial Susceptibility Testing and Therapy, 349 Prevention, 349

Chapter 25 Achromobacter, Rhizobium, Ochrobactrum, and Similar Organisms, 351

General Characteristics, 351 Epidemiology, 351 Pathogenesis and Spectrum of Disease, 351

Laboratory Diagnosis, 353 Antimicrobial Susceptibility Testing and Therapy, 355 Prevention, 356

Chapter 26 Chryseobacterium,

Sphingobacterium, and Similar Organisms, 358

General Characteristics, 358 Epidemiology, 358 Pathogenesis and Spectrum of Disease, 358

Laboratory Diagnosis, 358 Antimicrobial Susceptibility Testing and Therapy, 360 Prevention, 360

Chapter 27 AleaHgenes, Bordetetta

(Non-pertussis), Comamonas, and Similar Organisms, 363

General Characteristics, 363 Epidemiology, 363 Pathogenesis and Spectrum of Disease, 363

Laboratory Diagnosis, 363 Antimicrobial Susceptibility Testing and Therapy, 368 Prevention, 369

Chapter 20

Section 6:

Chapter 21

Section 7:

Chapter 22

Chapter 28 Vibrio, Aeromonas, Plesiomonas, and Chromobacterium, 371

General Characteristics, 371 Epidemiology, 371 Pathogenesis and Spectrum of Disease, 371

Laboratory Diagnosis, 373 Antimicrobial Susceptibility Testing and Therapy, 378 Prevention, 378

Section 9: Gram-Negative Bacilli and coccobacilli (macconkey-

Negative, Oxidase-Positive)

Chapter 29 Sphingomonas paucimobilis and Similar Organisms, 380

General Considerations, 380 Epidemiology, Spectrum of Disease, and Antimicrobial Therapy, 380 Laboratory Diagnosis, 380 Prevention, 382 Chapter 30 MoraxeUa, 384

General Characteristics, 384 Epidemiology, Spectrum of Disease, and Antimicrobial Therapy, 384 Laboratory Diagnosis, 384 Prevention, 387 Chapter 31 EikeneUa and Similar Organisms, 389

General Characteristics, 389 Epidemiology, Spectrum of Disease, and Antimicrobial Therapy, 389 Laboratory Diagnosis, 389 Prevention, 392 Chapter 32 PasteureUa and Similar Organisms, 393

General Characteristics, 393 Epidemiology, Spectrum of Disease, and Antimicrobial Therapy, 393 Laboratory Diagnosis, 393 Prevention, 396 Chapter 33 ActinobacSlus, Khigella,

Cardiobacterium, Capnocytophaga, and Similar Organisms, 397

General Characteristics, 397 Epidemiology, Spectrum of Disease, and Antimicrobial Therapy, 397

Laboratory Diagnosis, 397 Prevention, 402

Section 10: Gram-Negative Bacilli and coccobacilli

(MacConkey-Negative, Oxidase-Variable)

Chapter 34 Haemophilus, 403

General Characteristics, 403 Epidemiology, 403 Pathogenesis and Spectrum of Disease, 403

Laboratory Diagnosis, 403 Antimicrobial Susceptibility Testing and Therapy, 407 Prevention, 409

Section 11: Gram- Negative Bacilli That Are Optimally Recovered on Special Media

Chapter 35 Bartonella and Afipia, 410 Bartonella, 410 Afipiafelis, 414

Chapter 36 Campylobacter,; Arcobacter, and Helieobader, 416

Campylobacter and Arcobacter, 416 Helicobacter, 421

Chapter 37 Legionella, 424

General Characteristics, 424 Epidemiology and Pathogenesis, 424 Spectrum of Disease, 425 Laboratory Diagnosis, 426 Antimicrobial Susceptibility Testing and Therapy 428 Prevention, 428

Chapter 38 Brucella, 430

General Characteristics, 430 Epidemiology and Pathogenesis, 430 Spectrum of Disease, 431 Laboratory Diagnosis, 431 Antimicrobial Susceptibility Testing and Therapy, 433 Prevention, 433

Chapter 39 Bordetella pertussis and Bordetella parapertussis, 435

General Characteristics, 435 Epidemiology and Pathogenesis, 435 Spectrum of Disease, 435 Laboratory Diagnosis, 436 Antimicrobial Susceptibility Testing and Therapy, 438 Prevention, 438

Chapter 40 Franäseüa, 440

General Characteristics, 440 Epidemiology and Pathogenesis, 440 Spectrum of Disease, 440 Laboratory Diagnosis, 440 Antimicrobial Susceptibility Testing and Therapy, 442 Prevention, 442

Chapter 41 Streptobacillus moniliformis and Spirillum minus, 444

Streptobacillus moniliformis, 444 Spirillum minus, 445

Section 12: Gram-Negative Cocci

Chapter 42 Neisseria and Moraxella catarrhalis, 447

General Characteristics, 447 Epidemiology, 447 Pathogenesis and Spectrum of Disease, 447

Laboratory Diagnosis, 447 Antimicrobial Susceptibility Testing and Therapy, 452 Prevention, 452

Section 13: Anaerobic Bacteriology

Chapter 43 Overview and General Considerations, 455

General Characteristics, 455 Epidemiology, 455 Pathogenesis and Spectrum of Disease, 456 Specimen Collection and Transport, 457 . Anaerobic Media, 459 Prevention, 461

Chapter 44 Laboratory Considerations, 463

Macroscopic Examination of

Specimens, 463

Direct Detection Methods, 463

Cultivation, 463

Approach to Identification, 466

Antimicrobial Susceptibility

Testing and Therapy, 476

Section 14:

Mycobacteria and Other Bacteria with Unusual Growth Requirements

Chapter 45 Mycobacteria, 478

Mycobacterium tuberculosis Complex, 478 Nontuberculosis Mycobacteria, 481 Laboratory Diagnosis of Mycobacterial Infections, 486 Antimicrobial Susceptibility Testing and Therapy, 505 Prevention, 508

Chapter 46 Obligate Intracellular and Nonculturable Bacterial Agents, 510

Chlamydia, 510

Rickettsia, Orientia, Anaplasma, and Ehrlichia, 518 Coxiella, 521

Tropheryma whipplei, 522 Calymmatobaderium granubmaiis. 522

Chapter 47 Cell Wall-Deficient Bacteria: Mycoplasma and Ureaplasma, 525

General Characteristics, 525 Epidemiology and Pathogenesis, 525 Spectrum of Disease, 526 Laboratory Diagnosis, 526 Susceptibility Testing and Therapy, 529 Prevention, 532

Chapter 48 The Spirochetes, 533

Treponema, 533 Borrelia, 536 Leptospira, 539

Was this article helpful?

0 0
Bacterial Vaginosis Facts

Bacterial Vaginosis Facts

This fact sheet is designed to provide you with information on Bacterial Vaginosis. Bacterial vaginosis is an abnormal vaginal condition that is characterized by vaginal discharge and results from an overgrowth of atypical bacteria in the vagina.

Get My Free Ebook


Post a comment